Cargando…

In veteran outpatients, antibiotics remain significant risk factor for community-acquired Clostridiodes difficile infection

Background: An estimated 30% of antibiotic prescriptions in outpatient settings may be inappropriate. Antibiotic exposure increases an individual’s risk of Clostridioides difficile infection (CDI). To assess the prevalence of community-acquired CDI (CA-CDI) among patients without recent hospitalizat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akpoji, Ukwen, Wilson, Brigid, Chengsupanimit, Tayoot, Song, Sunah, Bej, Taissa, Jump, Robin, Perez, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	C. difficile
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614813/ http://dx.doi.org/10.1017/ash.2022.104

Ejemplares similares

Feasibility of a low-intensity intervention to improve antimicrobial use in outpatient settings
por: Wilson, Brigid, et al.
Publicado: (2023)

Outpatient antibiotic use for common infectious diagnoses: Patterns in telehealth during the emergence of COVID-19
por: Mongilardi, Nicole, et al.
Publicado: (2022)

Antibiotic exposure and acquisition of antibiotic-resistant gram-negative bacteria among outpatients at a US Veterans Affairs medical center
por: Akpoji, Ukwen C., et al.
Publicado: (2022)

Absence of racial and ethnic disparities in COVID-19 survival among residents of US Veterans’ Affairs community living centers
por: Alabdely, Mayyadah, et al.
Publicado: (2022)

Outpatient Antibiotic Use for Common Infectious Diagnoses: Patterns in Telehealth During the Emergence of COVID-19
por: Wilson, Brigid, et al.
Publicado: (2021)

Expanding the definition beyond surveillance criteria reveals a large burden of osteomyelitis caused by group B Streptococcus in the United States Veterans Health Administration
por: Chengsupanimit, Tayoot, et al.
Publicado: (2022)

Neither Race nor Ethnicity Impact the Mortality of Residents of Veterans Affairs Community Living Center With COVID-19
por: Alabdely, Mayyadah H., et al.
Publicado: (2023)

Clostridioides difficile: A diagnostic intervention
por: Alsoubani, Majd, et al.
Publicado: (2022)

Clostridioides difficile Is Not Difficult to Predict in Hospital Settings
por: Alexander, Kinta, et al.
Publicado: (2021)

Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
por: Kristen, Zeitler, et al.
Publicado: (2023)

Clinical Characteristics and Fecal Microbiome in Recurrent Versus Nonrecurrent Clostridioides difficile Infection
por: Lanjewar, Swapnil, et al.
Publicado: (2021)

Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
por: Rao, A. Krishna, et al.
Publicado: (2022)

Evaluation of the genomic epidemiology and transmission of Clostridioides difficile infection across a community
por: Tesini, Brenda, et al.
Publicado: (2022)

Role of diagnostic stewardship in reducing healthcare facility-onset Clostridioides difficile infections
por: Shallal, Anita, et al.
Publicado: (2022)

Examining the impact of the COVID-19 pandemic on hospital-associated Clostridioides difficile infection
por: Ray, Michael, et al.
Publicado: (2023)

Did Clostridioides difficile Testing and Infection Rates Change During the COVID-19 Pandemic?
por: Hawes, Armani, et al.
Publicado: (2021)

Clostridioides difficile infection (CDI) treatment outcomes and recurrence factor at a pediatric hospital
por: Tran, Martin Tuan, et al.
Publicado: (2022)

Prospective audit and feedback of Clostridioides difficile PCR at the time of ordering increases appropriateness of testing
por: Tassone, Daniel, et al.
Publicado: (2022)

Characteristics of antibiotic exposures for surgical procedures prior to Clostridioides difficile diagnosis—Minnesota, 2018
por: D’Heilly, Paige, et al.
Publicado: (2022)

Impact of Two-Step Testing Algorithm on Reducing Hospital-Onset Clostridioides difficile Infections
por: Navalkele, Bhagyashri, et al.
Publicado: (2021)

Effects of a hard stop for C. difficile testing: Provider uptake and patient outcomes
por: Doughman, Danielle, et al.
Publicado: (2023)

Efficacy and Safety of Investigational Microbiome Drug SER-109 for Treatment of Recurrent Clostridioides difficile Infection
por: McGovern, Barbara, et al.
Publicado: (2021)

Impact of exposure to potentially contaminated hospital beds on risk of hospital-onset C. difficile infection
por: Witt, Lucy, et al.
Publicado: (2022)

Impact of early identification of patients meeting testing criteria for Clostridioides difficile on standard infection ratios
por: Krier, Brad, et al.
Publicado: (2023)

Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection
por: Cohen, Stuart, et al.
Publicado: (2022)

Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection
por: Sims, Matthew, et al.
Publicado: (2023)

235. In outpatient clinics serving Veterans, antibiotic prescriptions precede a minority of antibiotic-associated adverse events
por: Wilson, Brigid, et al.
Publicado: (2020)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI
por: Sims, Matthew, et al.
Publicado: (2023)

325. Invasive and Non-Invasive Osteomyelitis Caused by Group B Streptococcus Infection Among Veterans
por: Bej, Taissa A, et al.
Publicado: (2020)

Minimal Mortality Among Veterans with Urine Cultures Positive for Group B Streptococcus
por: Mongilardi, Nicole, et al.
Publicado: (2021)

Mortality Among Veterans’ Affairs Community Living Center (CLC) Residents with COVID-19
por: Bej, Taissa, et al.
Publicado: (2021)

Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review
por: Gupta, Akshita, et al.
Publicado: (2021)

Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
por: Huhulescu, Steliana, et al.
Publicado: (2011)

Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291
por: Buckley, Anthony M., et al.
Publicado: (2011)

Change to hospitalist providers had a minimal influence on overall antibiotic use in a VA long-term care setting
por: Bej, Taissa, et al.
Publicado: (2023)

220. Characteristics and Outcomes of Veterans with Invasive Group B Streptococcal Infection Vary with the Type of Syndrome
por: Zappernick, Taissa, et al.
Publicado: (2019)

2190. Influence of Microbiological Culture Results on Antibiotic Choice for Veterans with Hospital-Acquired Pneumonia
por: Lee Anne. Christian, Robbie, et al.
Publicado: (2019)

206. Variations in the frequency and impact of polymicrobial cultures in adults with invasive Group B Streptococcal (GBS) infection at the US Veterans Health Administration
por: Briggs, Janet, et al.
Publicado: (2019)

466. Elevated Risk of Invasive Group B Streptococcal Infection Among Veterans with Poorly Controlled Diabetes Mellitus or at Extremes for Body Mass Index
por: Wilson, Brigid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vj10n5nn5gji009n8ida4kk2ug